Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1/2 1

Status

Completed 4Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1FED 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 5004Neoplasms 4197Prostatic Neoplasms 2428Carcinoma, Non-Small-Cell Lung 2265Colorectal Neoplasms 2053Lung Neoplasms 1705Multiple Myeloma 1459Lymphoma 1405Leukemia, Myeloid, Acute 1382Neoplasm Metastasis 1374Melanoma 1270Pancreatic Neoplasms 1200Leukemia 1196Ovarian Neoplasms 1192Lymphoma, Non-Hodgkin 1132Precursor Cell Lymphoblastic Leukemia-Lymphoma 1091Head and Neck Neoplasms 1056Leukemia, Lymphocytic, Chronic, B-Cell 994Lymphoma, Follicular 897Colonic Neoplasms 895Brain Neoplasms 876Stomach Neoplasms 857Recurrence 853Carcinoma, Hepatocellular 846Glioblastoma 841Lymphoma, Large B-Cell, Diffuse 771Rectal Neoplasms 759Uterine Cervical Neoplasms 728Carcinoma, Renal Cell 705Hodgkin Disease 698

Interventions

Sirolimus 1Sildenafil Citrate 1Picibanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Lymphangioma × Clear all
NCT00975819 2026-01-06

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Boston Children's Hospital

Phase 2 Completed
61 enrolled 7 charts
Classical hematology

Tufted angioma, Lymphangioma, Thrombocytopenia

NCT05050149 2025-01-17

Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations

Palvella Therapeutics, Inc.

Phase 2 Completed
12 enrolled 7 charts

Lymphangioma

NCT01290484 2015-06-19

A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations

Stanford University

Phase 1/2 Completed
7 enrolled 5 charts

Lymphangioma, Lymphatic Abnormalities, Vascular Malformations

NCT00010452 2015-03-25

Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations

FDA Office of Orphan Products Development

Phase 2/3 Completed
150 enrolled

Lymphangioma, Lymphangioma, Cystic, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon âš¡